Sarcoma Foundation of America
The organization Jeffrey Thornton's parents and Dr. Jack Brooks started in a family basement in 2000 after Jeffrey's sarcoma diagnosis at age three, grown into the largest private funder of sarcoma research, paid for by a New York gala, a national race series and research awards that carry the names of people sarcoma took.
Financial profile
Sarcoma Foundation Of America Inc · EIN 52-2275294 · 501(c)(3)
| Fiscal year | Total revenue | Contributions | Program services | Total expenses | Net assets | Year end |
|---|---|---|---|---|---|---|
| FY2025 | $3,362,208 | $2,825,668 | $0 | $4,303,065 | $10,417,871 | Dec 2025 |
| FY2024 | $3,547,902 | $3,185,724 | $70,000 | $3,570,622 | $11,024,320 | Dec 2024 |
| FY2023 | $3,709,252 | $3,689,910 | $20,000 | $3,222,438 | $10,505,513 | Dec 2023 |
| FY2022 | $3,674,023 | $3,559,687 | $0 | $2,690,137 | $9,266,426 | Dec 2022 |
| FY2021 | $3,973,362 | $3,432,529 | $0 | $2,396,561 | $9,322,668 | Dec 2021 |
| FY2020 | $2,719,131 | $2,379,199 | $0 | $1,993,762 | $7,541,879 | Dec 2020 |
Figures exactly as reported. A blank cell was blank on the form. The fiscal year links to the filing.
Peer societies
Five societies SFA is read alongside.
SF
Sunbeam Foundation
An all volunteer California foundation channeling community fundraising into research grants aimed at curing…
4 companies named
INF
The IBC Network Foundation
A patient led drive to fund research and gather people around a neglected breast cancer
MRA
Melanoma Research Alliance
The world's largest private nonprofit funder of melanoma research, structured so every donated dollar reaches…
140 companies named
RAN
Research Advocacy Network
A training force that turns patient advocates into full contributors to cancer research
BCAN
Bladder Cancer Advocacy Network
The network John and Diane Quale founded in 2005, when bladder cancer research was in its infancy and there…
21 companies named
Who backs SFA
Every company SFA names publicly as a supporter, exactly as published. Companies also named by other associations on Sociogene come first.
| Company | Support as published | Also named by |
|---|---|---|
| Boehringer Ingelheim | Corporate partner | AAD AAFP AAO AAPA AAHA +3 |
| Cozen O'Connor | Meeting sponsor | AAPA ABI ACB DBA MHI +3 |
| EMD Serono | Meeting sponsor | AANEM ACR AOSSM ASRO ASRM +3 |
| Genentech | Corporate partner | AMCP AcademyHealth AAAAI AAFP AAN +3 |
| Greenberg Traurig | Meeting sponsor | ANA CBA CREWN CA DVDB +3 |
| Piper Sandler | Meeting sponsor | ANS CBA DI GDMP ILC +3 |
| Stryker | Corporate partner | ACS ASCA AAOS AAOHN AAST +3 |
| Morrison Foerster | Meeting sponsor | CBA CBA IIB ICI NAS +2 |
| Servier | Meeting sponsor | ASH ASPHO ASA BIO COA +2 |
| SpringWorks TherapeuticsPublished as Springworks | Corporate partner | ACS AAN ACMGG ANA ASCO +1 |
| Paul, Weiss | Meeting sponsor | ACB AALS IIB SC |
| Clifford Chance | Meeting sponsor | IAPP |
| US WorldMeds | Meeting sponsor | ASTCT |
| Aadi BiosciencePublished as AADI | Corporate partner | Only SFA, so far |
| Adaptimmune | Corporate partner | Only SFA, so far |
| Deciphera | Corporate partner | Only SFA, so far |
| Immunome | Meeting sponsor | Only SFA, so far |
| JT Magen | Meeting sponsor | Only SFA, so far |
| O'Melveny | Meeting sponsor | Only SFA, so far |
| Parabilis MedicinesPublished as Parabilis | Meeting sponsor | Only SFA, so far |
| Vintage Financial Partners | Meeting sponsor | Only SFA, so far |
Sources: 2 published lists, read October 2026
2026 Stand Up to Sarcoma Gala Sponsors. Read October 7, 2026. Company sponsors of the 2026 Stand Up to Sarcoma Gala in New York.
Our Corporate Partners. Read October 7, 2026. Companies SFA lists as current corporate partners supporting its mission.
Who backs SFA's peers, but not SFA
Companies named publicly by at least one of SFA's five peer societies, and not found in SFA's reviewed public records.
| Company | SF | MRA | BCAN | Peers |
|---|---|---|---|---|
| Bristol Myers SquibbPublished as BMS | Named | Named | 2 of 3 | |
| Merck | Named | Named | 2 of 3 | |
| Pfizer | Named | Think Tank Title Sponsor | 2 of 3 | |
| 26 North | Named | 1 of 3 | ||
| AbbVie | Named | 1 of 3 | ||
| Agenus | Named | 1 of 3 | ||
| Alice + Olivia | Named | 1 of 3 | ||
| Alpine Investors | Named | 1 of 3 | ||
| American Industrial Partners | Named | 1 of 3 | ||
| Antares Capital | Named | 1 of 3 | ||
| Apax Partners | Named | 1 of 3 | ||
| Apollo | Named | 1 of 3 | ||
| Ares Management | Named | 1 of 3 | ||
| AstellasPublished as Astellas (Astellas | Pfizer alliance logo) | Named | 1 of 3 | ||
| AstraZeneca | Think Tank Title Sponsor | 1 of 3 | ||
| Audax Private Debt | Named | 1 of 3 | ||
| Bank of AmericaPublished as BOA | Named | 1 of 3 | ||
| BC Partners | Named | 1 of 3 | ||
| Benefit Street Partners | Named | 1 of 3 | ||
| Bimini Bay OutfittersPublished as Bimini-Bay | Named | 1 of 3 | ||
| BlackRock | Named | 1 of 3 | ||
| BlackstonePublished as Blackstone Group LP | Named | 1 of 3 | ||
| Blue Owl Capital | Named | 1 of 3 | ||
| BMO Capital Markets | Named | 1 of 3 | ||
| Brigade Capital Management | Named | 1 of 3 | ||
| Brinley Partners | Named | 1 of 3 | ||
| Brownstein Hyatt Farber SchreckPublished as Brownstein, Hyatt, Farber & Schreck | Named | 1 of 3 | ||
| Cahill Gordon & Reindel | Named | 1 of 3 | ||
| Cars4CausesPublished as Cars4Causes_Logo | Named | 1 of 3 | ||
| Castle BiosciencesPublished as Castle | Named | 1 of 3 | ||
| CG Oncology | Think Tank Title Sponsor | 1 of 3 | ||
| ChevronPublished as Chevron Matching Gifts | Named | 1 of 3 | ||
| Citi | Named | 1 of 3 | ||
| ClaudentPublished as CLDNT | Named | 1 of 3 | ||
| CURE | Named | 1 of 3 | ||
| CVC Capital Partners | Named | 1 of 3 | ||
| Daiichi Sankyo | Named | 1 of 3 | ||
| Davis Polk & Wardwell | Named | 1 of 3 | ||
| Debevoise & Plimpton | Named | 1 of 3 | ||
| DermTech | Named | 1 of 3 | ||
| DLA Piper | Named | 1 of 3 | ||
| enGene | Named | 1 of 3 | ||
| Evolution Credit PartnersPublished as Evolution Credit Partners Management, LLC | Named | 1 of 3 | ||
| Exact SciencesPublished as Exact Sciences Laboratories LLC | Named | 1 of 3 | ||
| Ferring PharmaceuticalsPublished as Ferring | Think Tank Title Sponsor | 1 of 3 | ||
| Fidelity Brokerage Services | Named | 1 of 3 | ||
| Fitch RatingsPublished as Fitch-raitings | Named | 1 of 3 | ||
| Flare Therapeutics | Named | 1 of 3 | ||
| Fortinbras Enterprises | Named | 1 of 3 | ||
| Foundation Medicine | Named | 1 of 3 | ||
| Franklin Templeton Investments | Named | 1 of 3 | ||
| Freshfields Bruckhaus Deringer USPublished as Freshfields Bruckhaus Deringer LLP | Named | 1 of 3 | ||
| Fried, Frank, Harris, Shriver & Jacobson | Named | 1 of 3 | ||
| General Atlantic | Named | 1 of 3 | ||
| Gibson, Dunn & Crutcher | Named | 1 of 3 | ||
| Giles Enterprises | Named | 1 of 3 | ||
| GoldenTree Asset Management | Named | 1 of 3 | ||
| Goldman SachsPublished as Goldman | Named | 1 of 3 | ||
| Golub Capital | Named | 1 of 3 | ||
| Goodwin Procter | Named | 1 of 3 | ||
| GTCR | Named | 1 of 3 | ||
| Guggenheim Partners | Named | 1 of 3 | ||
| Hellman & Friedman | Named | 1 of 3 | ||
| Holland & KnightPublished as HollandKnight | Named | 1 of 3 | ||
| Hopkins & CarleyPublished as HopkinsCarley_Logo_thumb | Named | 1 of 3 | ||
| HPS Investment PartnersPublished as HPS | Named | 1 of 3 | ||
| HSBC Bank | Named | 1 of 3 | ||
| ImmunityBio | Named | 1 of 3 | ||
| Immunocore | Named | 1 of 3 | ||
| Intermediate Capital Group | Named | 1 of 3 | ||
| Investcorp | Named | 1 of 3 | ||
| IO Biotech | Named | 1 of 3 | ||
| Iovance | Named | 1 of 3 | ||
| Iovance Biotherapeutics | Named | 1 of 3 | ||
| Jefferies Financial Group | Named | 1 of 3 | ||
| Johnson & Johnson | Think Tank Title Sponsor | 1 of 3 | ||
| KenvuePublished as JJ-new-name-kenvue | Named | 1 of 3 | ||
| Khaite | Named | 1 of 3 | ||
| King & Spalding | Named | 1 of 3 | ||
| Kirkland & EllisPublished as KirklandEllis | Named | 1 of 3 | ||
| KKRPublished as Kohlberg Kravis Roberts & Co. | Named | 1 of 3 | ||
| L'OrealPublished as LOreal-ACD | Named | 1 of 3 | ||
| L'Oreal Paris | Named | 1 of 3 | ||
| Latham & WatkinsPublished as Latham-Watkins | Named | 1 of 3 | ||
| Leonard Green & Partners | Named | 1 of 3 | ||
| Lilly | Named | 1 of 3 | ||
| Linklaters | Named | 1 of 3 | ||
| Looney Consulting | Named | 1 of 3 | ||
| Macquarie Group | Named | 1 of 3 | ||
| Madison Dearborn Partners | Named | 1 of 3 | ||
| Max Mara | Named | 1 of 3 | ||
| Mayer Brown | Named | 1 of 3 | ||
| Melan SuncarePublished as melan-logo | Named | 1 of 3 | ||
| Merrill LynchPublished as Merrill Lynch, Pierce, Fenner & Smith Inc. | Named | 1 of 3 | ||
| Microsoft | Named | 1 of 3 | ||
| MidOcean Partners | Named | 1 of 3 | ||
| Milbank | Named | 1 of 3 | ||
| Mizuho Securities USA | Named | 1 of 3 | ||
| MJX Asset Management | Named | 1 of 3 | ||
| Moderna | Named | 1 of 3 | ||
| Moran Insurance | Named | 1 of 3 | ||
| Morgan Stanley | Named | 1 of 3 | ||
| MUFGPublished as Mitsubishi UFJ Financial Group, Inc. (MUFG) | Named | 1 of 3 | ||
| Mural Oncology | Named | 1 of 3 | ||
| MV Credit Partners | Named | 1 of 3 | ||
| Natera | Named | 1 of 3 | ||
| Natixis | Named | 1 of 3 | ||
| Nella Holdings | Named | 1 of 3 | ||
| NeraCare | Named | 1 of 3 | ||
| Network Financial PrintingPublished as NFP | Named | 1 of 3 | ||
| New Mountain Capital | Named | 1 of 3 | ||
| New York PostPublished as nypost.com | Named | 1 of 3 | ||
| NovartisPublished as Novartios | Named | 1 of 3 | ||
| O'Melveny & Myers | Named | 1 of 3 | ||
| Oak Hill Capital Management | Named | 1 of 3 | ||
| Obsidian TherapeuticsPublished as obsidian | Named | 1 of 3 | ||
| Overland & Shanahan | Named | 1 of 3 | ||
| Paul Hastings | Named | 1 of 3 | ||
| Paul, Weiss, Rifkind, Wharton & GarrisonPublished as Paul, Weiss, Rifkin, Wharton & Garrison LLP | Named | 1 of 3 | ||
| Perella Weinberg Partners | Named | 1 of 3 | ||
| Photocure | Named | 1 of 3 | ||
| PlayStationPublished as PlayStation Cares | Named | 1 of 3 | ||
| PNC Bank | Named | 1 of 3 | ||
| PRIME Education | Named | 1 of 3 | ||
| Prophet Solutions | Named | 1 of 3 | ||
| Proskauer Rose | Named | 1 of 3 | ||
| Protara Therapeutics | Named | 1 of 3 | ||
| Raymond James Investment Banking | Named | 1 of 3 | ||
| Rayward Apparel | Named | 1 of 3 | ||
| Regeneron | Named | 1 of 3 | ||
| Relmada Therapeutics | Named | 1 of 3 | ||
| Replimune | Named | 1 of 3 | ||
| Ropes & Gray | Named | 1 of 3 | ||
| Salty Weapon | Named | 1 of 3 | ||
| Scotiabank | Named | 1 of 3 | ||
| SeilerPublished as seiler_logo | Named | 1 of 3 | ||
| Sidley Austin | Named | 1 of 3 | ||
| Silver Rock Financial | Named | 1 of 3 | ||
| Simpson Thacher & BartlettPublished as Simpson | Named | 1 of 3 | ||
| SkinCeuticalsPublished as Skinc | Named | 1 of 3 | ||
| Sol Labs | Named | 1 of 3 | ||
| Sony Music Entertainment | Named | 1 of 3 | ||
| Stone Canyon Industries | Named | 1 of 3 | ||
| Stone Point Capital | Named | 1 of 3 | ||
| Sullivan & Cromwell | Named | 1 of 3 | ||
| Sundercover | Named | 1 of 3 | ||
| Tecta America | Named | 1 of 3 | ||
| The Carlyle Group | Named | 1 of 3 | ||
| Thoma Bravo | Named | 1 of 3 | ||
| ToadfishPublished as TF-Logo / toadfish.com | Named | 1 of 3 | ||
| TPG Angelo Gordon | Named | 1 of 3 | ||
| Tyra BiosciencesPublished as Tyra | Think Tank Title Sponsor | 1 of 3 | ||
| U.S. Bank | Named | 1 of 3 | ||
| UBS | Named | 1 of 3 | ||
| UBS Investment Bank | Named | 1 of 3 | ||
| UroGen PharmaPublished as UroGen | Think Tank Title Sponsor | 1 of 3 | ||
| Veritas CapitalPublished as Veritas | Named | 1 of 3 | ||
| Warburg Pincus | Named | 1 of 3 | ||
| Weil, Gotshal & Manges | Named | 1 of 3 | ||
| White & CasePublished as white-case | Named | 1 of 3 |
The outside view
The organization Jeffrey Thornton's parents and Dr. Jack Brooks started in a family basement in 2000 after Jeffrey's sarcoma diagnosis at age three, grown into the largest private funder of sarcoma research, paid for by a New York gala, a national race series and research awards that carry the names of people sarcoma took.
- Authority
- Build
- Outward
- Operational
Their shape
The Movement
Gathered around a cause, and built to move.
The Movement is mission-led and built to mobilize, organized around changing something in the world. Its gift is passion and external impact, its challenge is turning momentum into something that lasts.
Also reads toward The Frontier and The Legacy.
Strengths
Not an official page of Sarcoma Foundation of America. Sociogene does not consult. Everything here comes from public sources, dated and linked. Something wrong here? Tell us what we missed.